Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 242.4 INR -3.73% Market Closed
Market Cap: 5.5B INR
Have any thoughts about
Jenburkt Pharmaceuticals Ltd?
Write Note

Jenburkt Pharmaceuticals Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jenburkt Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Jenburkt Pharmaceuticals Ltd
BSE:524731
Cash from Financing Activities
-â‚ą72.8m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Financing Activities
â‚ą30.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Financing Activities
-â‚ą16.8B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Financing Activities
-â‚ą58.9B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Financing Activities
-â‚ą26.5B
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Financing Activities
â‚ą52.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jenburkt Pharmaceuticals Ltd
Glance View

Market Cap
5.5B INR
Industry
Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 730 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The firm's manufacturing plant is located in Sihor-Gujarat. The firm's products are exported to approximately 13 countries globally.

JENBURPH Intrinsic Value
781.67 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Jenburkt Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
-72.8m INR

Based on the financial report for Sep 30, 2024, Jenburkt Pharmaceuticals Ltd's Cash from Financing Activities amounts to -72.8m INR.

What is Jenburkt Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-8%

Over the last year, the Cash from Financing Activities growth was 67%. The average annual Cash from Financing Activities growth rates for Jenburkt Pharmaceuticals Ltd have been -8% over the past three years .

Back to Top